SCHULMAN AMY W 4
4 · ALNYLAM PHARMACEUTICALS, INC. · Filed Jun 27, 2024
Insider Transaction Report
Form 4
SCHULMAN AMY W
Director
Transactions
- Exercise/Conversion
Common Stock
2024-06-25$131.21/sh+8,500$1,115,285→ 16,936 total - Sale
Common Stock
2024-06-25$240.00/sh−8,500$2,040,000→ 8,436 total - Exercise/Conversion
Stock Option (right to buy)
2024-06-25−8,500→ 2,750 totalExercise: $131.21From: 2016-06-01Exp: 2025-06-01→ Common Stock (8,500 underlying)
Footnotes (2)
- [F1]All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on February 28, 2024.
- [F2]This stock option was fully vested and exercisable as of June 1, 2016.